Study on angiogenesis-targeting peptide modified iron oxide nanoparticles used in local magnetic hyperthermia in tumor-bearing nude mouse models

Tumor

Volumn 30, Issue 5, 2010, Pages 370-375

  Zhao, Yin Min ^a   Su, Bo ^a   Yang, Xiao Jun ^a   Tang, Liang ^a   Zhou, Cai Cun ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Diathermy; Iron compounds; Nanotubes, peptide; Neovascularization, pathologic; Xenograft model antitumor assays

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; ARGINYLGLYCYLASPARTIC ACID; ARGINYLGLYCYLASPARTIC ACID SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE CONJUGATE; DEXTRAN; INTEGRIN; IRON OXIDE; NANOCOATING; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG;

ANALYZER; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC THERAPY; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BINDING AFFINITY; CANCER INHIBITION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG BINDING; DRUG CONJUGATION; ELECTRIC FIELD; ELECTROMAGNETIC FIELD; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; IN VITRO STUDY; IN VIVO STUDY; MAGNETIC HYPERTHERMIA; MAGNETOTHERAPY; MOUSE; NONHUMAN; NUDE MOUSE; PARTICLE SIZE; PRECIPITATION; THERAPY EFFECT; TUMOR GROWTH; TUMOR VOLUME; UMBILICAL VEIN;

EID: 77954521166     PISSN: 10007431     EISSN: None     Source Type: Journal    
DOI: 10.3781/j.issn.1000-7431.2010.05.002     Document Type: Article

References (20)

1. MOROZ P, JONES S K, GRAY B N. Magnetically mediated hyperthermia: current status and future directions [J]. Int J Hyperthermia, 2002, 18 (4) :267-284.
2. LATORRE M, RINALDI C. Applications of magnetic nanoparticles in medicine: magnetic fluid hyperthermia [J]. P R Health Sci J, 2009, 28 (3) :227-238.
3. SHELDRAKE H M, PATTERSON L H. Function and antagonism of beta 3 integrins in the development of cancer therapy [J]. Curr Cancer Drug Targets, 2009, 9 (4) :519-540.
4. MERKEL O M, GERMERSHAUS O, WADA C K, et al. Integrin alpha V beta 3 targeted gene delivery using RGD peptidomimetic conjugates with copolymers of PEGylated poly (ethylene imine) [J]. Bioconjug Chem, 2009, 20(6) :1270-1280.
5. LE RENARD P E, BUCHEGGER F, PETRI-FINK A, et al. Local moderate magnetically induced hyperthermia using an implant formed in situ in a mouse tumor model [J]. Int J Hyperthermia, 2009, 25 (3) :229-239.
6. JOHANNSEN M, THIESEN B, JORDAN A, et al. Magnetic fluid hyperthermia (MFH) reduces prostate cancer growth in the orthotopic Dunning R3327 rat model [J]. Prostate, 2005, 64(3) :283-292.
7. PENG X H, QIAN X M, MAO H, et al. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy [J]. Int J Nano-medicine, 2008, 3 (3) :311-321.
8. 3 complexes combined with magnetic fluid hyperthermia selectively target liver cancer cells [J]. World J Gastroenterol, 2009, 15 (24) :2995-3002.
9. JOHANNSEN M, GNEVECKOW U, TAYMOORJAN K, et al. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: result of a prospective phase I trial [J ]. Int J Hyperthermia, 2007, 23 (3) :315-323.
10. SONVICO F, MORNET S, VASSEUR S, et al. Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments [J]. Biocorjug Chem, 2005, 16(5) :1181-1188.
11. CHEN T J, CHENG T H, CHEN C Y. Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI [J]. J Biol Inorg Chem, 2009, 14 (2) :253-260.
12. LIU S, HSIEH W Y, JIANG Y, et al. Evaluation of a (99m) Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha (V) beta 3-positive breast cancer [J]. Biocorjug Chem, 2007, 18 (2) :438-446.
13. ZHANG C, JUGOLD M, WOENNE E C, et al. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner [J]. Cancer Res, 2007, 67 (4) :1555-1562.
14. PARDOE H, CLARK P R, ST PIERRE T G, et al. A magnetic resonance imaging based method for measurement of tissue iron concentration in liver arterially embolized with ferrimagnetic particles designed for magnetic hyperthermia treatment of tumors [J]. Magn Reson Imaging, 2003, 21 (5) :483-488.
15. JORDAN A, SCHOLZ R, WUST P, et al. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo [J]. Int J Hyperthermia, 1997, 13 (6) :587-605.
16. ZHAI Y, XIE H, GU H. Effects of hyperthermia with dextran magnetic fluid on the growth of grafted 1122 tumor in mice [J]. Int J Hyperthermia, 2009, 25 (1) :65-71.